Mainz Biomed's ColoAlert Added to DoctorBox Portfolio in Germany.

martes, 2 de diciembre de 2025, 8:09 am ET1 min de lectura
MYNZ--

Mainz Biomed, a molecular genetics diagnostic company, has partnered with DoctorBox, a digital health pioneer in Germany, to add its ColoAlert test to their portfolio. The test is designed for early cancer detection and will be analyzed by European Oncology Lab. Colorectal cancer is a common and preventable cancer in Germany, with around 60,000 new cases diagnosed annually.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios